Brief: Precision Biosciences Completes License Deal With TG Therapeutics For Cell Therapy Azer-Cel

TG Therapeutics

09/01/2024 12:39

Jan 9 (Reuters) - Precision BioSciences Inc  DTIL.O :
    * PRECISION BIOSCIENCES COMPLETES LICENSE DEAL WITH TG
THERAPEUTICS FOR CELL THERAPY AZER-CEL IN TREATMENT OF
AUTOIMMUNE DISEASES
    * PRECISION BIOSCIENCES-CO TO RECEIVE $17.5 MILLION IN
UPFRONT,
NEAR-TERM PAYMENTS WITH POTENTIAL FOR UP TO $288 MILLION IN
OTHER DEVELOPMENT MILESTONE PAYMENTS
    * PRECISION BIOSCIENCES INC - UPFRONT CASH AND NEAR-TERM
PAYMENTS
EXPECTED TO EXTEND PRECISION'S CASH RUNWAY INTO FIRST HALF OF
2026
    * PRECISION BIOSCIENCES INC - EXPECTS TO REPORT THAT IT HAD
APPROXIMATELY $116 MILLION IN CASH AND CASH EQUIVALENTS AS OF
DECEMBER 31, 2023

Source text for Eikon:  ID:nBw7J4dYTa 
Further company coverage:  DTIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))